CAS: 1338934-59-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MKC8866 REF: TM-T15594CAS: 1338934-59-0 | 99.35% | 87.00 €~2,024.00 € | Thu 09 May 24 | |
MKC8866 REF: AN-AG01EOOWCAS: 1338934-59-0 | 99% | 56.00 €~969.00 € | Thu 09 May 24 | |
MKC8866 REF: 3D-NDC93459CAS: 1338934-59-0 | Min. 95% | 92.00 €~1,009.00 € | Tue 21 May 24 |
MKC8866
CAS:1338934-59-0
MKC8866 is a selective IRE1 RNase inhibitor (IC50: 0.29 μM in human vitro). MKC8866 inhibits …
Formula:
C18H19NO7
Purity:
99.35%
Color and Shape:
Solid
Molecular weight:
361.35
Ref: TM-T15594
1mg | 87.00 € | |
5mg | 184.00 € | |
10mg | 298.00 € | |
25mg | 502.00 € | |
50mg | 727.00 € | |
100mg | 1,016.00 € | |
500mg | 2,024.00 € | |
1ml*10 (DMSO) | 198.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ref: AN-AG01EOOW
1mg | 56.00 € | |
5mg | 101.00 € | |
10mg | 168.00 € | |
25mg | 239.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
MKC8866
CAS:1338934-59-0
MKC8866 is an experimental anti-cancer drug that is currently in Phase II clinical trials. It …
Formula:
C18H19NO7
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
361.35 g/mol
Ref: 3D-NDC93459
1mg | 92.00 € | |
2mg | 156.00 € | |
5mg | 333.00 € | |
10mg | 500.00 € | |
25mg | 1,009.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024